ABGX Abgenix (MM)

Abgenix to Host Conference Call on First Quarter 2005 Financial Results FREMONT, Calif., April 18 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) will hold a conference call on Tuesday, April 26, 2005 at 1:30 p.m. PT, 4:30 p.m. ET, to discuss first quarter financial results and to provide an update on the company's antibody discovery, development, and manufacturing activities. Bill Ringo, president and chief executive officer of Abgenix, will host the call. To participate in the teleconference, please dial 800-761-0748 fifteen minutes before the conference begins. International callers should dial 617-614-2706. The pass code is 89600730. The call will also be webcast live at http://www.abgenix.com/. A replay of the call will be available until May 10, 2005 on the company's website or by dialing 888-286-8010. International callers should dial 617-801-6888. The replay participant code is 86920645. About Abgenix Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company's antibody development platform includes a leading technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through its own development efforts and the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at http://www.abgenix.com/. DATASOURCE: Abgenix, Inc. CONTACT: Ami Knoefler, Senior Director, Corporate Communications and Investor Relations, of Abgenix, Inc., +1-510-284-6350, or +1-510-284-6605 Web site: http://www.abgenix.com/

Copyright